Laboratory Issues and West Nile Virus Hema Kapoor MD. SM (NRM)

Slides:



Advertisements
Similar presentations
Nick Curry, MD, MPH Infectious Diseases Prevention Section
Advertisements

Purpose (You may click to go to the specific section or proceed through the presentation) Briefly review West Nile virus (WNV) ecology and epidemiology.
Instructions for users This slide presentation provides an overview of the diagnostic and laboratory testing aspects of JE. Below many of the slides, there.
Plague CDC, AFIP. Diseases of Bioterrorist Potential Learning Objectives Describe the epidemiology, mode of transmission, and presenting symptoms of disease.
Mosquito-borne Arbovirus Surveillance in West Virginia Rachel Radcliffe, DVM, MPH CDC Career Epidemiology Field Officer Division of Infectious Disease.
Blood Products Advisory Committee Meeting Harold S. Gaithersburg, MD December 14, 2010 Harold S. Margolis, MD Chief, Dengue Branch Centers for Disease.
6/03/031 Hepatitis C –Update Laboratory Issues Hema Kapoor MD. SM Virology Section Manager Bureau of Laboratories Michigan Department of Community Health.
West Nile Virus: Surveillance and Clinical Issues Anne Kjemtrup, DVM, MPVM, Ph.D. California Department of Public Health Vector-Borne Disease Section 1.
Use of avidity reagent. Panbio Buffered Avidity Reagent Mild protein-denaturing solution that may be useful in differentiating recent infections from.
Epidemiology of West Nile Virus in Georgia
Re-emergence of locally acquired Dengue Fever in Palm Beach County, Florida Robert Parkes, MD; Sandra Warren, MPH, JoEllen Alvarez, RN, MPH, Barbara.
WNV Human Case Investigation and Reporting Kimberly Signs, DVM Michigan Department of Community Health.
By Abhinay Sharma Bhugoo.  1648: First recognized outbreak of YF occurring in the New World. YF virus most likely introduced by slave- trading vessels.
Algorithms and Testing Results for West Nile/Arbovirus Testing (2002) used at Michigan Department of Community Health H. Kapoor, P. Clark, F. P. Downes,
DIAGNOSIS OF WEST NILE VIRUS INFECTION IN ANIMALS Jon S. Patterson, DVM, PhD, DACVP Roger K. Maes, DVM, PhD Diagnostic Center for Population and Animal.
Testing algorithms used at Bureau of Labs Michigan Department of Community Health Information on testing algorithms for processing and reporting serological.
Viral Encephalitis John Nuara, Salwa Touma, Kelly Wines Microbiology and the Control of Infectious Diseases April 22, 2003.
1 Module 5 Supplemental Information Laboratory Diagnostics, Specimen Collection, and Biosafety Issues.
Comparison of the Diagnostic Value of the Standard Tube Agglutination Test and the ELISA IgG and IgM in Patients with Brucellosis Presented by Dr. Md.
DEPARTMENT OF HEALTH RESEARCH INSTITUTE FOR TROPICAL MEDICINE Ebola Virus Disease Diagnosis Catalino S. Demetria, DVM.
Laboratory Investigation
Arbovirus, 2010 May 20, 2010 Susan Stowers Greg Chrislip Jonah Long Danae Bixler 1.
West Nile Virus Michigan Mary Grace Stobierski, DVM,MPH,DACVPM Michigan Dept. Community Health.
West Nile Virus Jo Hofmann, MD State Epidemiologist for Communicable Disease Washington State Department of Health Focus on clinical aspects of human infection.
REAL-TIME SCREENING FOR WEST NILE VIRUS (WNV) OF ORGAN DONORS Claudia Chinchilla, CLSpMB 1, Jaime Siriban, CLS 1, Dem Brucal, CLS 1, James Schellenberg,
CHIKUN GUNYA FEVER. INTRODUCTION  Caused by an Alpha Virus  Spread by bite of Aedes aegypti mosquito which usually bite during day light hours.  the.
Instructions for users This slide presentation provides an overview of the components of a population-based surveillance system for JE. Please use this.
Hema Kapoor MD. SM (NRM) Virology Section manager Bureau of laboratories Michigan Department of community Health Lansing Michigan Laboratory Issues and.
Arboviruses: Update and Review Dave Warshauer, PhD, D(ABMM) Deputy Director, Communicable Diseases Wisconsin State Laboratory of Hygiene WISCONSIN STATE.
DIAGNOSIS OF HIV INFECTION THE LABORATORY BY DR. K.BUJJIBABU.MD.
Serum procalcitonin and C-reactive protein in children with community- acquired pneumonia K.Gogvadze, I.Guramishvili, I.Chkhaidze, K.Nemsadze, T.Maglakelidze.
West Nile Virus Surveillance Ingrid Garrison, DVM, MPH, DACVPM State Public Health Veterinarian September 16, 2015.
Theresa L. Smith, MD, MPH Division of Vector-Borne Infectious Diseases Centers for Disease Control and Prevention Fort Collins, CO West Nile Virus Epidemiology.
Update on Assay Development George J. Dawson, Ph.D. Infectious Diseases: Core R & D Abbott Laboratories West Nile Virus.
Panbio Dengue ELISAs.
SEARO –CSR Early Warning and Surveillance System Module Case Definitions.
West Nile Virus Michigan Mary Grace Stobierski, DVM,MPH,DACVPM Michigan Dept. Community Health.
Current Status of Issues Related to West Nile virus testing and donor screening Hira Nakhasi, Ph.D. Director, DETTD/OBRR CBER, FDA.
Progress in West Nile virus Testing and Donor Screening Hira Nakhasi, Ph.D. Director, DETTD/OBRR CBER, FDA.
Other Animal Species Large and growing list of animals that have tested positive for WNV Current list at U.S. Geological Survey’s National Wildlife Health.
A rbovirus means “arthropod-borne Transmitted by: * Arthropodes: female mosquito's and female ticks * Mother tick transmit virus.
LABORATORY DIAGNOSIS OF VIRAL INFECTIONS. In developing countries, virological specimens will need to be transferred from district laboratories to regional.
Arboviral Surveillance in Maryland, 2003 Kimberly C. Mitchell, MPH West Nile Virus Coordinator January 29, 2004.
Development of Standard Reagents for WNV NAT M. Rios, A. Grinev, K. Sirnivasan, O. Wood, S. Daniel, I. Hewlett CBER/FDA.
LAB. DIAGNOSIS OF VIRUSES 5 methods are used for diagnosis in the virology laboratory: 1.Direct microscopy 2.Cultivation of viruses 3.Serology 4. Detection.
West Nile Virus Kimberly Signs, DVM Michigan Department of Community Health.
Surveillance & Environmental Health West Nile Virus Seroprevalence: Results of Enhanced Surveillance Program.
Avidity determination of IgG in diagnosis of tick-born encephalitis Hana Zelená Jiří Januška Jan Raszka Virology department, National Reference Laboratory.
Validation of Nucleic Acid and Serological Tests to Screen Blood and Plasma donors for Acute infection with West Nile virus Hira Nakhasi, Ph.D. Director,
Links Between Testing and Reporting from the Laboratory Perspective Jyotsna Shah, Ph.D, CMLD, MBA February 25, 2004.
Update on West Nile Virus – United States, Eileen C. Farnon, MD Arboviral Diseases Branch Division of Vector-Borne Infectious Diseases Centers.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Recent Serologic Studies with Potential Impact on WNV Blood Screening Wayne Hogrefe, Harry Prince Focus Technologies.
Public Health Perspective on SARS Diagnostics Stephen M. Ostroff Deputy Director National Center for Infectious Diseases, CDC.
CBER Update on status of West Nile virus test, lot release and validation panel development Indira Hewlett, Ph.D CBER/FDA Blood Products Advisory Committee.
IgM ELISA CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY Jan. 1998, p. 7–10 Vol. 5, No. 1 Copyright © 1998, American Society for Microbiology.
Dengue fever caused by dengue virus (DENV), a member of Flaviviridae leads to large global disease burden. Detection of immunoglobulin M (IgM) and nucleic.
Lee County Mosquito Control District’s Response to Suspected Cases and Outbreaks of Mosquito- borne Diseases.
1 Special eSHARE Webinar: Overview of ELR vocabulary associated with Zika, dengue, and chikungunya viruses New Conference Number: Participant.
POSTER TEMPLATE BY: om EVALUATION OF A NEW ELISA DIAGNOSTIC KIT FOR CHIKUNGUNYA AND APPLICATION IN AN OUTBREAK SITUATION Caroline.
COMPARISON OF LABORATORY DIAGNOSTIC PROCEDURES FOR DETECTION OF MYCOPLASMA PNEUMONIAE IN COMMUNITY OUTBREAKS KATHLEEN A. THURMAN, NICHOLAS D. WALTER, STEPHANIE.
Abbott Laboratories ConfidentialPage 1 Update on West Nile Virus George J. Dawson, Ph.D. Abbott Laboratories.
Diagnostic Testing for Zika Virus Frederick S. Nolte, PhD, D(ABMM), F(AAM) Professor and Vice-Chair for Laboratory Medicine Department of Pathology and.
Specimen Collection Guide for Cattle or Horses with Suspected Rabies, West Nile Virus Encephalitis or Bovine Spongiform Encephalopathy (BSE) Adapted from.
Unexplained Neurologic Illness in Children – Malkangiri, Odisha, India, 2014 Authors: Priyakanta Nayak1, Mohan Papanna1, Aakash Shrivastava1, Pradeep.
From: Clinical and Laboratory Diagnosis of Dengue Virus Infection
Case Definition: HEPATITIS C
Update on CBER HIV-1 Subtype panel
Hepatitis Primary Care: Clinics in Office Practice
ImmunoWELL Zika Virus Serology.
Presentation transcript:

Laboratory Issues and West Nile Virus Hema Kapoor MD. SM (NRM) April 9, 2003 Laboratory Issues and West Nile Virus Hema Kapoor MD. SM (NRM) Virology Section manager Bureau of laboratories Michigan Department of community Health Lansing Michigan June 3, 2003

Laboratory Issues and West Nile Virus Arboviruses Laboratory Diagnosis Investigation of 2002 WNV outbreak in Michigan Plans for 2003-Lab perspective June 3, 2003

The arboviruses Arthropod-borne viruses(mosquitoes, sand-flies, fleas, ticks, lice, etc) Enveloped RNA viruses -4 families Flaviviridae-WNV isolated in 1937 in west Nile district of Uganda in Eastern Africa. June 3, 2003

Arboviral encephalitides Mosquito eastern equine encephalitis (EEE) western equine encephalitis (WEE) St. Louis encephalitis (SLE) La Crosse (LAC) Ticks Powassan June 3, 2003

New modes of transmission WNV Transmission Dead end host New modes of transmission Dead end host June 3, 2003

Laboratory Issues and West Nile Virus Arboviruses Laboratory Diagnosis Investigation of 2002 WNV outbreak in Michigan Plans for 2003-Lab perspective June 3, 2003

Immune Response in WNV Infection April 9, 2003 Immune Response in WNV Infection ELISA P/N #pfu/ml IgM 150 IgG WN viremia Igm-peak is reached from day3-8 days. Cases bled too early for WNV may show false negative results. -5 -4 -3 -2 -1 0 1 2 3 4 5 6 7 8 9 10 DAYS POST ONSET illness June 3, 2003 Ref: 4th National WNV Conf. 2003 www.cdc.gov

Laboratory Diagnosis of Human cases Specimens Cerebrospinal fluid (CSF) CSF and Serum combination Sera- Acute and Convalescent (obtained at least 8 d and 22 d post onset respectively) Least preferred single serum sample Ref: Antibody Capture ELISA (IgM & IgG) Protocol. CDC Fort Collins, colorado CDC Neutralization Test Protocol. CDC Fort Collins, colorado June 3, 2003

Laboratory Diagnosis of Human cases contd Laboratory Tests Capture enzyme-linked immunosorbent assay (MAC-ELISA-IgM). Capture enzyme-linked immunosorbent assay (MAC-ELISA-IgG) and Plaque Reduction Neutralization Test (PRNT) Ref: Antibody Capture ELISA (IgM & IgG) Protocol. CDC Fort Collins, colorado CDC Neutralization Test Protocol. CDC Fort Collins, colorado June 3, 2003

Serological Testing Criteria at Michigan CSF Paired sera (Ac. at least 8 days and conv at least 22 days post onset) Single serum P/N ratio >/= 10 positive P/N 2-10 equivocal and requested for a serum sample. P/N ratio >/=5 presumptive. P/N 2-5 equivocal. IgG Tests -A four-fold rise in titre to distinguish a recently acquired infection from a past infection. PRNT was performed on all specimens showing a four fold increase in IgG titer. P/N ratio- same as in paired sera. A convalescent serum requested on equivocals . PRNT To rule out the cross- reactions between WNV and other arbovirus infections (SLE, EEE and CGV). MAC-ELISA IgM performed in Singlet. Positive MAC-ELISA repeated in duplicate June 3, 2003

WNV RNA(-) results are meaningless West Nile Virus Nucleic Acid Amplification Tests (NAAT) Diagnostic Testing Higher persistent levels of WNV RNA found in immuno-compromised patients Improved sensitivity with better quality of diagnostic samples or virus concentration methods? WNV RNA(-) results are meaningless June 3, 2003

Identifying viremic / antibody negative “window phase” patients West Nile Virus Nucleic Acid Amplification Tests (NAAT) Diagnostic Testing Identifying viremic / antibody negative “window phase” patients Low levels WNV RNA found in clinically ill, immuno- competent patients (i. e., WN fever) June 3, 2003

Laboratory Issues and West Nile Virus Arboviruses Laboratory Diagnosis Investigation of 2002 WNV outbreak in Michigan Plans for 2003-Lab perspective June 3, 2003

Weekly WNV Testing (Aug-Nov 02) Total Specimens (Jan, 02-Dec, 02)-2910 June 3, 2003 June 3, 2003 June 3, 2003

How we handled the 2002 outbreak in the laboratory ? Triaged the samples Virology section and intersection staff worked collectively 6 days a week June 3, 2003

CSF at MDCH 0 day IgM ELISA 1st Run Neg Pos Investigation 5 6day April 9, 2003 CSF at MDCH 0 day IgM ELISA 1st Run Report via EPIC Neg Notification Via EPIC to Submitter, LDH & EPI 4 day Pos Investigation Confirmed positive reports Via EPIC 5 6day IgM ELISA 2nd Run pos Quantity Sufficient QNS To report a Probable case request a serum sample Equivocal Request a convalescent serum sample June 3, 2003

Acute Serum at MDCH (0day) IgM ELISA 2nd run Reported a presumptive positive (LAB) & probable case (EPI) Via EPIC with a request for a convalescent serum Pos Investigation Notification via EPIC to Sub, LHD & EPI Neg IgM ELISA 1st run Report Via EPIC Convalescent serum No 4x increase 4x rise in titer Yes PRNT on pair Confirmed positive reports Via EPIC Arboviral Panel No PRNT on acute serum (Convalescent sample not possible ) Pos June 3, 2003

Single serum collected too early Single serum with documented CNS symptoms or paired sera without 4X increase in titer IgM ELISA (+) PRNT (-) Test for SLE, EEE and CGV Probable WNV Case Neg Yes Single serum collected too early (0-8 d) post onset No Paired sera Yes No WNV Case June 3, 2003

Laboratory Issues and West Nile Virus Arboviruses Laboratory Diagnosis Investigation of 2002 WNV outbreak in Michigan Plans for 2003-Lab perspective June 3, 2003

Plans for 2003 Human Surveillance No triaging of samples Test whole panel Two LT positions in virology for WNV testing Cross training IgM capture ELISA testing on CSF and Paired serum Attempt culture on for WNV June 3, 2003

Issues with Persistence of IgM antibodies Getting Ready for summer of 2003 contd Issues with Persistence of IgM antibodies June 3, 2003

Longevity of Human WN Virus-Reactive IgM in Serum Days P.I. N Positive MAC-ELISA Total (%) Ave. P/N (Range) Positive (%) Equivocal 200 22 13 (60) 4 17 (77) 6.0 (3.0-10.8) 300-400 21 9 (43) 2 11 (52) 4.0 (31.-6.5) 500 12 5 (42) 6 (60) 5.0 (3.1-6.9) June 3, 2003 Ref: 4th National WNV Conf. 2003 www.cdc.gov

Confirmed positive reports Acute Serum at MDCH 2003 Testing Hold and request for the Convalescent serum PRNT on acute serum Pos No CNS symptoms + Approval of Virology Lab Manger Neg IgM ELISA 1st Run IgM ELISA 2nd Run Report Yes 4x rise in titer PRNT (IgG) on pair Confirmed positive reports Via EPIC No 4x increase Arboviral Panel June 3, 2003

Persistence of IgM antibodies In CSF-No studies Published-47d MDCH observations-Three cases with igM positive 110d 141d 199d June 3, 2003

Over wintering adult Culex mosquitoes Human Cases ? To Sum Up……. June 3, 2003